Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Cysteamine bitartrate

EU orphan designation number: EU/3/14/1306   
Active ingredient: Cysteamine bitartrate
Indication: Treatment of Huntington’s disease
Sponsor: Chiesi Farmaceutici S.p.A.
Via Palermo 26/A, 43122 Parma, Italia

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/07/2014 Orphan designation EMA/OD/070/14 (2014)5531 of 29/07/2014
7/02/2017 Change of name and/or address of sponsor
21/11/2017 Change of name and/or address of sponsor
18/05/2018 Transfer of orphan designation EMA/OD/070/14/T/01 (2018)3151 of 16/05/2018